Fungal Dx 2024

Dear Friends and Colleagues,

It is a great honor and pleasure for us to invite you to participate in the FungalDx2024, scheduled to take place December 4-5, 2024, in Bethesda, MD, USA.

Target Audience

This interactive postgraduate workshop is intended for anyone who want to improve their knowledge and understanding in the area of Fungal Diagnostics, including:

• Physicians and trainees in infectious disease, critical care, transplantation, haemato-oncology, dermatology, pediatrics, and other clinical specialties dealing with fungal infections
• Clinical microbiology laboratory directors/consultants
• CPEP microbiology fellows
• Clinical laboratory scientists (diagnostic microbiology/mycology) 
• PhD students and Postdoctoral researchers 
• Scientists from infectious disease in vitro diagnostics (IVD) industry or pharmaceutical companies

Contents:

• FungalDx2024 is an amazing opportunity to learn how we can choose the best diagnostic test to detect a fungal infection, how to interpret the results, which antifungal is best to use for treatment (Currently available and novel antifungals under development), and how to choose the best platform in resource-rich and resource-limited clinical environments.
• Eight scientific sessions in two days with world-renowned speakers will be a diverse and interactive learning experience.  Each scientific session feature will start with a case study followed by discussion of critical algorithms/flowcharts that can be used for diagnosis and detection of fungal infections, useful for both clinical microbiology laboratories and physicians managing these infections in different clinical settings.
• The following topics will be covered: Practical algorithms for diagnosis and surveillance of fungal infections, fungal nomenclature, epidemiology and global burden of fungal infections, direct microscopic examination of clinical samples, culture, cytology and histopathology, serology, antigen detection and point of care testing, molecular diagnostics, MALDI-TOF (Yeast vs. Mold), antifungal susceptibility testing (phenotypic and molecular assays to identify resistance), novel therapeutics, and infection-prevention of medically important fungi.

• Amir Seyedmousavi. PhD, D(ABMM), F(ECMM) - NIH, Bethesda, USA 
• Malcolm Richardson, PhD, F(ECMM) - University of Manchester, UK

THE BETHESDAN HOTEL, TAPESTRY COLLECTION BY HILTON

8120 Wisconsin Avenue, Bethesda, Maryland, 20814-3624, USA 

'ISHAM-Fungal Dx 2024' will start at 8.00 AM on Wednesday 4 December 2024 and will end on Thursday 5 December 2024 at 6.00 PM. 

 The workshop language will be English.  

Registration will open between February 5 and November 20, 2024.